Sleep disorders Flashcards
sleep disorder symptoms
difficulty initiating sleep, difficulty maintaining sleep, early awakenings, nonrestorative sleep with ample opportunity for sleep
Sleep disorder
insomnia sx w/ sig waking sx or impairment (daytime drowsiness, drowsy driving)
Excessive sleepiness
chronic excessive sleepiness affects 5% of general population, impact of drowsy driving (100,000 MVA/year)
Risk factors of sleep disorders
female, oler, divorced, stressors at work, perception of health, medica and psychiatric disorders, medications, drug abuse
Stages of sleep
REM (20-25%), Non REM (75-80%), 1 cycle typically last 1.5-2 hours, stage 1 relaxed wakefulness, initiates sleep, stage 2- lighter sleep, provides rest for brain and muscles, Stage 3- provides rest, feeling of rejuvenation, stage 4-immune system enhanced, growth hormone released
Norepi, histamine, ACh
Promote wakefulness
Serotonin
neurons in the brainstem inhibit motor activity and lessen sensory input, promoting emergence of slow wave sleep
Opiates and GABA
promote sleep, GABA is more active during NREM
Hypocretin
found in hypothalamus, loss of hypocretin neurons linked to narcolepsy
Non-pharm approaches
use bedroom only for sex and sleep, relaxation therapy, stimulus control, use alcohol/nicotine w/ caution, sleep restriction, exercise, avoid eating close to bed time
Pharm treatment
BZD, triazolam (Halcion), Temazepam (Restoril), estazolam (Prosam), recommended for short term use only; nonBZD- Zolpidem (ambien), Zaleplon (Sonata), Eszopicolone (Lunesta), Ramelteon (Rozerem), Desyrel, benedryl
Triazolam (Halcion)
shortest acting BZD
Temazepam (Restoril)
intermediate acting, slow onset, 15-30 mg PO once daily
Estazolam (Prosom)
intermediate acting, fast onset
Zolpidem (Ambien) dose
5-10 mg PO once daily at bedtime
Eszopiclone (Lunesta) dose
1-3 mg PO once daily at bedtime
MOA of non BZD
binds to a1 subtype of the BZD receptor
Non BZDs pearls
very quick onset (30 mins), short-acting little to no hangover effect, eszopiclone is the only one approved for long term use causes metallic taste, sedation, all are C-IV controlled
Ramelteon (Rozerem) MOA
melatonin agonist, not controlled substance, goal to restor circadian rhythm, use for jet lag
Trazodone (Desyrel)
not FDA approved for sleep but only used for sleep, DOC for insomnia in elderly, no addiction potential, no ACh ADRs
Diphenhydramine (Benadryl)
OTC, lots of ACh ADRs, tolerance develops
Supplements for sleep
Valerian, chamomile, melatonin
Sequence of agents employed
Temazepam, zolpidem/zaleplon, trazodone, if early morning awakening, use temazepam, if daytime anxiety use long acting BZD
Sleep attacks
REM sleep at anytime during the waking state, last 10-30 mins
Cataplexia
loss of muscle tone in face/limbs, often induced by emotions or laughter
Hypnogogic hallucinations
perceptual disturbances that occur during sleep attack
Sleep paralysis
inability to breath deeply, move limbs or speak, often occurring upon falling asleep
Narcolepsy treatment
Dextroamphetamine (Adderall), Methylphenidate, modafanil (Provigil), Armdafinil (Nuvigil)
MOA of Modafanil (Provigil)
inc wakefulness via a adrenergic and GABA modulating mechanisms, no effect on cataplexy, efficacy similar to stimulants